Arbovirus Testing Market Size to Hit USD 2.16 Billion by 2035

Arbovirus Testing Market Size in 2026

The global arbovirus testing market size was valued at USD 1.35 billion in 2025 and is projected to grow from USD 1.41 billion in 2026 to approximately USD 2.16 billion by 2035, expanding at a CAGR of 4.80% from 2026 to 2035. The market growth is primarily driven by the rising incidence of mosquito-borne diseases such as dengue, Zika, and chikungunya, largely fueled by climate change and rapid urbanization.

Read Also: Theranostics Market

Arbovirus Testing Market Key Takeaways

• North America dominated the market with a 42% share in 2025.
• Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
• By type, ELISA-based tests held the largest share of 49% in 2025.
• RT-PCR-based tests are projected to witness the fastest growth.
• By end-use, diagnostic laboratories accounted for the largest market share.
• Research centers are expected to expand rapidly in the coming years.

What Drives the Arbovirus Testing Market?

The arbovirus testing market is experiencing steady growth due to the increasing global burden of mosquito-borne infections. Diseases such as dengue and Zika are becoming more widespread due to climate change, which expands mosquito habitats and increases transmission rates.

Technological advancements in molecular diagnostics, including RT-PCR and point-of-care testing solutions like LAMP-based devices, are enabling faster and more accurate detection. Additionally, increased funding for surveillance programs, such as global health initiatives, is strengthening diagnostic infrastructure worldwide.

Role of AI in Arbovirus Testing

Artificial Intelligence (AI) is transforming arbovirus diagnostics by significantly improving accuracy and efficiency. AI-powered systems can:

• Achieve diagnostic accuracy rates exceeding 99%
• Reduce false positives by 22% using machine learning algorithms
• Deliver test results in under 65 minutes through automated workflows

AI-enhanced ELISA readers and molecular diagnostic tools improve serotype differentiation and reduce cross-reactivity. Moreover, AI models analyze large datasets to predict outbreaks, track mosquito populations, and forecast transmission patterns, enabling proactive public health responses.

Key Market Trends

Climate Change and Vector Expansion

Rising global temperatures and changing weather patterns are expanding mosquito habitats, increasing the spread of arboviruses into new regions.

Technological Advancements in Diagnostics

Innovations such as PCR-based testing and improved ELISA assays are enabling rapid, accurate, and decentralized testing, even in remote areas.

Rising Disease Prevalence

The growing number of dengue and Zika cases worldwide is driving demand for efficient diagnostic solutions.

Rapid Urbanization

Urban population growth, particularly in tropical regions, is accelerating disease transmission and increasing pressure on healthcare systems.

Future Market Opportunities

Expansion in Emerging Markets

Countries with high disease prevalence are investing heavily in diagnostic infrastructure. For instance, India has established hundreds of surveillance hospitals to improve dengue detection.

Infrastructure Development

The development of portable and rapid diagnostic tools is enabling testing in rural and underserved regions. Integration with digital health platforms and telemedicine is also enhancing real-time disease monitoring.

Segmental Insights

By Type

ELISA-Based Tests

ELISA-based tests dominated the market in 2025 due to their cost-effectiveness, scalability, and ability to detect both current and past infections through antigen and antibody identification.

RT-PCR-Based Tests

RT-PCR tests are expected to grow at the fastest rate, as they offer superior sensitivity and specificity, making them the gold standard for early virus detection.

By End-Use

Diagnostic Laboratories

Diagnostic laboratories held the largest share due to their advanced infrastructure, high testing capacity, and ability to perform complex molecular and serological tests.

Research Centers

Research centers are expected to grow rapidly as they focus on developing innovative diagnostic technologies such as CRISPR-based and isothermal testing methods.

Regional Insights

North America

North America led the market in 2025 due to strong healthcare infrastructure, advanced laboratory networks, and significant investments in disease surveillance and outbreak preparedness.

Asia-Pacific

Asia-Pacific is expected to witness the fastest growth, driven by tropical climates, frequent outbreaks, and improving healthcare infrastructure in countries like India and Thailand.

Europe

Europe is emerging as a significant market due to increasing awareness and rising prevalence of arboviral diseases, along with advancements in diagnostic technologies.

Latin America

Latin America is experiencing notable growth due to high infection rates and increased government investments in diagnostic capabilities.

Middle East & Africa

The region is expected to grow steadily, supported by rising healthcare investments and efforts to combat tropical diseases through improved diagnostic infrastructure.

Arbovirus Testing Market Companies

Key players operating in the global market include:

• Abbott
• Thermo Fisher Scientific Inc.
• NovaTec Immundiagnostica GmbH
• Agilent Technologies, Inc.
• QIAGEN
• Bio-Rad Laboratories, Inc.
• EUROIMMUN Medical Laboratory Diagnostics AG
• Merck KGaA
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• GT Molecular
• Response Biomedical
• Grifols Diagnostic Solutions

Recent Developments

• In March 2025, Bolivia strengthened its dengue response capabilities with international support, improving laboratory diagnostics and surveillance networks.
• In January 2025, QIAGEN received U.S. FDA clearance for its QIAstat-Dx Gastrointestinal Panel, enhancing diagnostic capabilities.
• In April 2024, Grifols received CE mark approval for its Procleix ArboPlex Assay for detecting multiple arboviruses.

Conclusion

The arbovirus testing market is poised for steady growth over the forecast period, driven by rising disease prevalence, climate change, and technological advancements in diagnostics. With increasing adoption of AI-powered tools and expanding healthcare infrastructure, the market is expected to play a crucial role in global infectious disease management and outbreak prevention.

Get Sample: https://www.precedenceresearch.com/sample/8035